Altimmune (ALT) Other Accumulated Expenses (2014 - 2026)

Altimmune (ALT) has 9 years of Other Accumulated Expenses data on file, last reported at $313000.0 in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 458.93% year-over-year to $313000.0 in Q1 2026; TTM through Mar 2026 was $313000.0, a 458.93% increase from a year earlier, with the FY2025 full-year figure at $315000.0, up 472.73% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $313000.0, down from $315000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for ALT reached as high as $315000.0 in Q4 2025 and fell as low as $54000.0 in Q3 2024.
• Historically, Other Accumulated Expenses has averaged $137727.3 across 5 years, with a median of $103000.0 in 2022.
• Across the five-year window, Other Accumulated Expenses tumbled 55.65% in 2024 and soared 472.73% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $103000.0 in 2022, then grew by 20.39% to $124000.0 in 2023, then tumbled by 55.65% to $55000.0 in 2024, then surged by 472.73% to $315000.0 in 2025, then dropped by 0.63% to $313000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $313000.0 in Q1 2026, $315000.0 in Q4 2025, and $177000.0 in Q3 2025.